Table 3

Post-KA chronic epilepsy in mice

Administration
mode
SELatent
period
SRSComorbiditiesReferences
SystemicStarts within 15–30 min
Lasts for
2–6 h
27% mortality
2–3 dRarely observed
Infrequent
Hyperactivity
Delayed mortality
Hu et al. (1998)
McKhann et al. (2003)
Benkovic et al. (2004)
Puttachary et al. (2015)
Umpierre et al. (2016)
Intra-HCStarts within 30 min
Lasts for
3–12 h
<5% mortality
2–14 d1–2 per week
Highly variable
eSRS+++
Cognitive impairment
Hyperexcitability
Depression (lesioned ventral
hippocampus)
Bouilleret et al. (1999)
Riban et al. (2002)
Gouder et al. (2003)
Gröticke et al. (2008)
Lee et al. (2012)
Zeidler et al. (2018)
Intra-AmStarts within 20 min
Usually terminated
at 30–40 min
No mortality
3–12 d3 per day (±2.5)AnxietyAraki et al. (2002)
Shinoda et al. (2004)
Mouri et al. (2008)
Tanaka et al. (2010)
Li et al. (2012)
Liu et al., 2013)
Supra-HCLasts for 2–7 h
<10% mortality
4–13 d2.8 per day 
(±3.5)
No dataBedner et al. (2015)
Jefferys et al. (2016)
Pitsch et al. (2019)
IntranasalStarts within 15–30 min
Lasts for 1–5 h
∼6.5% mortality
15–30 dReportedIncreased locomotionChen et al. (2002)
Duan et al. (2006)
Zhang et al. (2008)
Lu et al. (2008)
Sabilallah et al. (2016)
  • Am, amygdala; eSRS, electrographic SRSs; HC, hippocampus; SE, status epilepticus; SRS, spontaneous recurrent seizures